Article
The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy.
International journal of radiation oncology, biology, physics - 1 Jul 2021
Yu Jia-Hua, Zhao Qing-Ya, Liu Yuan, Zhu Xue-Ru, Yang Zhang-Ru, Fu Xiao-Long, Cai Xu-Wei
Abstract excerpt
PURPOSE: Our previous findings have identified vitronectin (VTN) as a potential biomarker for radiation pneumonitis (RP) through proteomics and molecular mechanism studies. In a recent study, we further explored associations of plasma level and single nucleotide polymorphisms of VTN with the risk of RP in patients with lung cancer receiving radiation therapy. METHODS AND MATERIALS: A total of 165 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
